Stock Information
AbbVie Inc (ABBV)
Ticker Symbol: ABBV
Exchange: NYSE
Sector: Biotechnology
Market Cap: $369,100.61 mil
Piotroski score: 9
PE Ratio: 87.3792
EPS (TTM): 2.3828
Revenue (TTM): $34.44 M
Dividend Yield: 3.3046800382044%
ROE: 95.59%
Latest News
-
Trump tariff fallout: Some industries grapple with lingering effects one year later
Fri, Apr 3, 2026 7:30 AM
-
Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative
Fri, Apr 3, 2026 3:12 AM
-
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
Fri, Apr 3, 2026 12:40 AM
-
2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory
Thu, Apr 2, 2026 9:52 PM
-
Trump Slaps 100% Tariffs on Some Drug Imports. What to Know.
Thu, Apr 2, 2026 8:04 PM
-
The Rise of 6 Emerging Therapies in a Critical Spinal Cord Injury Market Void | DelveInsight
Thu, Apr 2, 2026 5:00 PM
-
AbbVie shares are trading lower after reports suggesting that the Trump administration is preparing to invoke Section 232 tariffs on pharmaceutical producers that don't already have a pricing agreement with the U.S. government.
Thu, Apr 2, 2026 2:14 PM
-
The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income
Thu, Apr 2, 2026 12:10 PM
-
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
Thu, Apr 2, 2026 12:00 PM
-
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
Thu, Apr 2, 2026 11:14 AM
Key Financials
Financial data not available